Bartholdi, D., Rubin, B. P., and Schwab, M. E. (1997). VEGF mRNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat. Eur. J. Neurosci. 9, 2549-2560.
Basso, D. M., Beattie, M. S., and Bresnahan, J. C. (1995). A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1-21.
Benton, R. L., and Whittemore, S. R. (2003). VEGF165 therapy exacerbates secondary damage following spinal cord injury. Neurochem. Res. 28, 1693-1703.
Carlton, S. M., Du, J., Tan, H. Y., Nesic, O., Hargett, G. L., Bopp, A. C., Yamani, A., Lin, Q., Willis, W. D., and Hulsebosch, C. E. (2009). Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury. Pain 147, 265-276.
Christensen, M. D., and Hulsebosch, C. E. (1997). Spinal cord injury and anti-NGF treatment results in changes in CGRP density and distribution in the dorsal horn in the rat. Exp. Neurol. 147, 463-475.
Citron, B. A., Arnold, P. M., Haynes, N. G., Ameenuddin, S., Farooque, M., Santacruz, K., and Festoff, B. W. (2008). Neuroprotective effects of caspase-3 inhibition on functional recovery and tissue sparing after acute spinal cord injury. Spine (Phila. Pa. 1976) 33, 2269-2277.
Detloff, M. R., Fisher, L. C., McGaughy, V., Longbrake, E. E., Popovich, P. G., and Basso, D. M. (2008). Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats. Exp. Neurol. 212, 337-347.
Deumens, R., Jaken, R. J., Knaepen, L., van der Meulen, I., and Joosten, E. A. (2009). Inverse relation between intensity of GFAP expression in the substantia gelatinosa and degree of chronic mechanical allodynia. Neurosci. Lett. 452, 101-105.
Deumens, R., Jaken, R. J., Marcus, M. A., and Joosten, E. A. (2007a). The CatWalk gait analysis in assessment of both dynamic and static gait changes after adult rat sciatic nerve resection. J. Neurosci. Methods 164, 120-130.
Deumens, R., Joosten, E. A., Waxman, S. G., and Hains, B. C. (2008). Locomotor dysfunction and pain: the scylla and charybdis of fiber sprouting after spinal cord injury. Mol. Neurobiol. 37, 52-63.
Deumens, R., Koopmans, G. C., Honig, W. M., Hamers, F. P., Maquet, V., Jerome, R., Steinbusch, H. W., and Joosten, E. A. (2006a). Olfactory ensheathing cells, olfactory nerve fibroblasts and biomatrices to promote long-distance axon regrowth and functional recovery in the dorsally hemisected adult rat spinal cord. Exp. Neurol. 200, 89-103.
Deumens, R., Koopmans, G. C., Honig, W. M., Maquet, V., Jerome, R., Steinbusch, H. W., and Joosten, E. A. (2006b). Chronically injured corticospinal axons do not cross large spinal lesion gaps after a multifactorial transplantation strategy using olfactory ensheathing cell/olfactory nerve fibroblast-biomatrix bridges. J. Neurosci. Res. 83, 811-820.
Deumens, R., Koopmans, G. C., Honig, W. M., Maquet, V., Jerome, R., Steinbusch, H. W., and Joosten, E. A. (2006c). Limitations in transplantation of astroglia-biomatrix bridges to stimulate corticospinal axon regrowth across large spinal lesion gaps. Neurosci. Lett. 400, 208-212.
Deumens, R., Koopmans, G. C., and Joosten, E. A. (2005). Regeneration of descending axon tracts after spinal cord injury. Prog. Neurobiol. 77, 57-89.
Deumens, R., Lubbers, M., Jaken, R. J., Meijs, M. F., Thurlings, R. M., Honig, W. M., Schachner, M., Brook, G. A., and Joosten, E. A. (2007b). Mice lacking L1 have reduced CGRP fibre in-growth into spinal transection lesions. Neurosci. Lett. 420, 277-281.
Donnelly, D. J., and Popovich, P. G. (2008). Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp. Neurol. 209, 378-388.
Facchiano, F., Fernandez, E., Mancarella, S., Maira, G., Miscusi, M., D'Arcangelo, D., Cimino-Reale, G., Falchetti, M. L., Capogrossi, M. C., and Pallini, R. (2002). Promotion of regeneration of corticospinal tract axons in rats with recombinant vascular endothelial growth factor alone and combined with adenovirus coding for this factor. J. Neurosurg. 97, 161-168.
Faulkner, J. R., Herrmann, J. E., Woo, M. J., Tansey, K. E., Doan, N. B., and Sofroniew, M. V. (2004). Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 24, 2143-2155.
Felix, E. R., Cruz-Almeida, Y., and Widerstrom-Noga, E. G. (2007). Chronic pain after spinal cord injury: What characteristics make some pains more disturbing than others? J. Rehabil. Res. Dev. 44, 703-716.
Gris, D., Marsh, D. R., Oatway, M. A., Chen, Y., Hamilton, E. F., Dekaban, G. A., and Weaver, L. C. (2004). Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J. Neurosci. 24, 4043-4051.
Gwak, Y. S., and Hulsebosch, C. E. (2009). Remote astrocytic and microglial activation modulates neuronal hyperexcitability and below-level neuropathic pain after spinal injury in rat. Neuroscience 161, 895-903.
Hains, B. C., and Waxman, S. G. (2006). Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci. 26, 4308-4317.
Hains, B. C., Yucra, J. A., and Hulsebosch, C. E. (2001). Reduction of pathological and behavioral deficits following spinal cord contusion injury with the selective cyclooxygenase-2 inhibitor NS-398. J. Neurotrauma 18, 409-423.
Hamers, F. P., Koopmans, G. C., and Joosten, E. A. (2006). Cat-Walk-assisted gait analysis in the assessment of spinal cord injury. J. Neurotrauma 23, 537-548.
Hamers, F. P., Lankhorst, A. J., van Laar, T. J., Veldhuis, W. B., and Gispen, W. H. (2001). Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries. J. Neurotrauma 18, 187-201.
Hargreaves, K., Dubner, R., Brown, F., Flores, C., and Joris, J. (1988). A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32, 77-88.
Herrera, J. J., Nesic-Taylor, D. O., and Narayana, P. A. (2009). Reduced vascular endothelial growth factor expression in contusive spinal cord injury. J. Neurotrauma 26, 995-1003.
Hofstetter, C. P., Holmstrom, N. A., Lilja, J. A., Schweinhardt, P., Hao, J., Spenger, C., Wiesenfeld-Hallin, Z., Kurpad, S. N., Frisen, J., and Olson, L. (2005). Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat. Neurosci. 8, 346-353.
Hulsebosch, C. E. (2008). Gliopathyensures persistent inflammation and chronic pain after spinal cord injury. Exp. Neurol. 214, 6-9.
Hulsebosch, C. E., Hains, B. C., Crown, E. D., and Carlton, S. M. (2009). Mechanisms of chronic central neuropathic pain after spinal cord injury. Brain Res. Rev. 60, 202-213.
Ji, R. R., Kawasaki, Y., Zhuang, Z. Y., Wen, Y. R., and Decosterd, I. (2006). Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway. Neuron Glia Biol. 2, 259-269.
Jones, T. B., McDaniel, E. E., and Popovich, P. G. (2005). Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr. Pharm. Des. 11, 1223-1236.
Kloos, A. D., Fisher, L. C., Detloff, M. R., Hassenzahl, D. L., and Basso, D. M. (2005). Stepwise motor and all-or-none sensory recovery is associated with nonlinear sparing after incremental spinal cord injury in rats. Exp. Neurol. 191, 251-265.
Koopmans, G. C., Brans, M., Gomez-Pinilla, F., Duis, S., Gispen, W. H., Torres-Aleman, I., Joosten, E. A., and Hamers, F. P. (2006). Circulating insulin-like growth factor I and functional recovery from spinal cord injury under enriched housing conditions. Eur. J. Neurosci. 23, 1035-1046.
Koopmans, G. C., Deumens, R., Brook, G., Gerver, J., Honig, W. M., Hamers, F. P., and Joosten, E. A. (2007). Strain and locomotor speed affect over-ground locomotion in intact rats. Physiol. Behav. 92, 993-1001.
Koopmans, G. C., Deumens, R., Buss, A., Geoghegan, L., Myint, A. M., Honig, W. H., Kern, N., Joosten, E. A., Noth, J., and Brook, G. A. (2009). Acute rolipram/thalidomide treatment improves tissue sparing and locomotion after experimental spinal cord injury. Exp. Neurol. 216, 490-498.
Koopmans, G. C., Deumens, R., Honig, W. M., Hamers, F. P., Steinbusch, H. W., and Joosten, E. A. (2005). The assessment of locomotor function in spinal cord injured rats: the importance of objective analysis of coordination. J. Neurotrauma 22, 214-225.
Krum, J. M., Mani, N., and Rosenstein, J. M. (2002). Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience 110, 589-604.
Krum, J. M., and Rosenstein, J. M. (1998). VEGF mRNA and its receptor flt-1 are expressed in reactive astrocytes following neural grafting and tumor cell implantation in the adult CNS. Exp. Neurol. 154, 57-65.
Li, M., Ona, V. O., Chen, M., Kaul, M., Tenneti, L., Zhang, X., Stieg, P. E., Lipton, S. A., and Friedlander, R. M. (2000). Functional role and therapeutic implications of neuronal caspase-1 and-3 in a mouse model of traumatic spinal cord injury. Neuroscience 99, 333-342.
Liu, Y., Figley, S., Spratt, S. K., Lee, G., Ando, D., Surosky, R., and Fehlings, M. G. (2010). An engineered transcription factor which activates VEGF-A enhances recovery after spinal cord injury. Neurobiol. Dis. 37, 384-393.
Mineur, P., Colige, A. C., Deroanne, C. F., Dubail, J., Kesteloot, F., Habraken, Y., Noel, A., Voo, S., Waltenberger, J., Lapiere, C. M., Nusgens, B. V., and Lambert, C. A. (2007). Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents. J. Cell Biol. 179, 1261-1273.
Moalem, G., Leibowitz-Amit, R., Yoles, E., Mor, F., Cohen, I. R., and Schwartz, M. (1999). Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5, 49-55.
Nepomuceno, C., Fine, P. R., Richards, J. S., Gowens, H., Stover, S. L., Rantanuabol, U., and Houston, R. (1979). Pain in patients with spinal cord injury. Arch. Phys. Med. Rehabil. 60, 605-609.
Nesic, O., Lee, J., Johnson, K. M., Ye, Z., Xu, G. Y., Unabia, G. C., Wood, T. G., McAdoo, D. J., Westlund, K. N., Hulsebosch, C. E., and Regino Perez-Polo, J. (2005). Transcriptional profiling of spinal cord injury-induced central neuropathic pain. J. Neurochem. 95, 998-1014.
Park, S. W., Yi, J. H., Miranpuri, G., Satriotomo, I., Bowen, K., Resnick, D. K., and Vemuganti, R. (2007). Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats. J. Pharmacol. Exp. Ther. 320, 1002-1012.
Patel, C. B., Cohen, D. M., Ahobila-Vajjula, P., Sundberg, L. M., Chacko, T., and Narayana, P. A. (2009). Effect of VEGF treatment on blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced magnetic resonance imaging. J. Neurotrauma 26, 1005-1016.
Plunkett, J. A., Yu, C. G., Easton, J. M., Bethea, J. R., and Yezierski, R. P. (2001). Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp. Neurol. 168, 144-154.
Ransohoff, R. M., and Perry, V. H. (2009). Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27, 119-145.
Rosenstein, J. M., and Krum, J. M. (2004). New roles for VEGF in nervous tissue-beyond blood vessels. Exp. Neurol. 187, 246-253.
Schwartz, M., Moalem, G., Leibowitz-Amit, R., and Cohen, I. R. (1999). Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci. 22, 295-299.
Siddall, P. J., McClelland, J. M., Rutkowski, S. B., and Cousins, M. J. (2003). A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury. Pain 103, 249-257.
Skold, M., Cullheim, S., Hammarberg, H., Piehl, F., Suneson, A., Lake, S., Sjogren, A., Walum, E., and Risling, M. (2000). Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration. Eur. J. Neurosci. 12, 3675-3686.
Sofroniew, M. V. (2005). Reactive astrocytes in neural repair and protection. Neuroscientist 11, 400-407.
Sondell, M., Lundborg, G., and Kanje, M. (1999). Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci. 19, 5731-5740.
Tanga, F. Y., Raghavendra, V., Nutile-McMenemy, N., Marks, A., and Deleo, J. A. (2006). Role of astrocytic S100beta in behavioral hypersensitivity in rodent models of neuropathic pain. Neuroscience 140, 1003-1010.
Vaquero, J., Zurita, M., de Oya, S., and Coca, S. (1999). Vascular endothelial growth/permeability factor in spinal cord injury. J. Neurosurg. 90, 220-223.
Widenfalk, J., Lipson, A., Jubran, M., Hofstetter, C., Ebendal, T., Cao, Y., and Olson, L. (2003). Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Neuroscience 120, 951-960.
Zhao, P., Waxman, S. G., and Hains, B. C. (2007a). Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury. J. Neurosci. 27, 2357-2368.
Zhao, P., Waxman, S. G., and Hains, B. C. (2007b). Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microglia by cysteine cysteine chemokine ligand 21. J. Neurosci. 27, 8893-8902.
